MARINO, MARCO
Distribuzione geografica
| Continente | # |
|---|---|
| EU - Europa | 458 |
| AS - Asia | 398 |
| NA - Nord America | 255 |
| AF - Africa | 31 |
| SA - Sud America | 13 |
| OC - Oceania | 6 |
| Continente sconosciuto - Info sul continente non disponibili | 1 |
| Totale | 1.162 |
| Nazione | # |
|---|---|
| US - Stati Uniti d'America | 238 |
| CN - Cina | 171 |
| IT - Italia | 158 |
| GB - Regno Unito | 64 |
| IN - India | 60 |
| CZ - Repubblica Ceca | 42 |
| DE - Germania | 36 |
| RU - Federazione Russa | 31 |
| FR - Francia | 30 |
| JP - Giappone | 24 |
| UA - Ucraina | 17 |
| IR - Iran | 16 |
| NL - Olanda | 16 |
| VN - Vietnam | 16 |
| TR - Turchia | 15 |
| HK - Hong Kong | 14 |
| UZ - Uzbekistan | 14 |
| CA - Canada | 12 |
| ES - Italia | 12 |
| KR - Corea | 12 |
| ID - Indonesia | 11 |
| TW - Taiwan | 11 |
| EG - Egitto | 9 |
| RO - Romania | 9 |
| AT - Austria | 7 |
| TH - Thailandia | 7 |
| IL - Israele | 6 |
| MY - Malesia | 6 |
| BR - Brasile | 5 |
| MK - Macedonia | 5 |
| MX - Messico | 4 |
| NZ - Nuova Zelanda | 4 |
| CI - Costa d'Avorio | 3 |
| DZ - Algeria | 3 |
| ET - Etiopia | 3 |
| IE - Irlanda | 3 |
| KE - Kenya | 3 |
| MA - Marocco | 3 |
| NO - Norvegia | 3 |
| PK - Pakistan | 3 |
| PL - Polonia | 3 |
| RS - Serbia | 3 |
| SA - Arabia Saudita | 3 |
| SE - Svezia | 3 |
| SG - Singapore | 3 |
| AR - Argentina | 2 |
| AU - Australia | 2 |
| BE - Belgio | 2 |
| CH - Svizzera | 2 |
| CL - Cile | 2 |
| FI - Finlandia | 2 |
| GH - Ghana | 2 |
| IQ - Iraq | 2 |
| JO - Giordania | 2 |
| NG - Nigeria | 2 |
| PE - Perù | 2 |
| PT - Portogallo | 2 |
| A1 - Anonimo | 1 |
| BG - Bulgaria | 1 |
| CO - Colombia | 1 |
| CU - Cuba | 1 |
| DK - Danimarca | 1 |
| GR - Grecia | 1 |
| HR - Croazia | 1 |
| HU - Ungheria | 1 |
| LK - Sri Lanka | 1 |
| LV - Lettonia | 1 |
| MC - Monaco | 1 |
| MD - Moldavia | 1 |
| PH - Filippine | 1 |
| SN - Senegal | 1 |
| TN - Tunisia | 1 |
| UY - Uruguay | 1 |
| ZA - Sudafrica | 1 |
| Totale | 1.162 |
| Città | # |
|---|---|
| Nanjing | 26 |
| Garden Grove | 24 |
| Turin | 22 |
| Wuhan | 17 |
| Tacoma | 16 |
| Milan | 15 |
| Nanning | 15 |
| Bukhara | 14 |
| Bedford | 13 |
| Rome | 13 |
| Shanghai | 13 |
| Zhengzhou | 12 |
| Houston | 11 |
| Central | 10 |
| Jakarta | 10 |
| Ashburn | 9 |
| Bonn | 9 |
| Chaoyang | 9 |
| Dong Ket | 9 |
| Frankfurt am Main | 9 |
| Guangzhou | 9 |
| Jinan | 9 |
| Hangzhou | 8 |
| Moscow | 8 |
| New York | 8 |
| Bangkok | 7 |
| Council Bluffs | 7 |
| Hyderabad | 7 |
| Torino | 7 |
| Florence | 6 |
| Kuala Lumpur | 6 |
| Pune | 6 |
| Amsterdam | 5 |
| Arlington | 5 |
| Beijing | 5 |
| Buffalo | 5 |
| Chicago | 5 |
| East Setauket | 5 |
| Hanoi | 5 |
| Istanbul | 5 |
| Kameino | 5 |
| Los Angeles | 5 |
| Newcastle upon Tyne | 5 |
| Notre Dame | 5 |
| Stalybridge | 5 |
| Vienna | 5 |
| Bengaluru | 4 |
| Bradford | 4 |
| Brescia | 4 |
| Cambridge | 4 |
| Dundee | 4 |
| Durham | 4 |
| Edirne | 4 |
| Genova | 4 |
| Kolkata | 4 |
| London | 4 |
| Mumbai | 4 |
| Parma | 4 |
| Parsippany | 4 |
| Sendai | 4 |
| Sezze | 4 |
| Taichung | 4 |
| Wilmington | 4 |
| Ann Arbor | 3 |
| Atlanta | 3 |
| Auckland | 3 |
| Bobbio | 3 |
| Charleston | 3 |
| Columbus | 3 |
| Curtarolo | 3 |
| Delhi | 3 |
| Des Moines | 3 |
| Dublin | 3 |
| Hartford | 3 |
| Krasnodar | 3 |
| Montréal | 3 |
| Naples | 3 |
| Paris | 3 |
| Richland | 3 |
| San Francisco | 3 |
| San Mateo | 3 |
| Seoul | 3 |
| Taipei | 3 |
| Zagazig | 3 |
| Abidjan | 2 |
| Amman | 2 |
| Atherstone | 2 |
| Bergen | 2 |
| Bologna | 2 |
| Boston | 2 |
| Chennai | 2 |
| Chester | 2 |
| Cinisello Balsamo | 2 |
| Cuenca | 2 |
| Curitiba | 2 |
| Duncan | 2 |
| Gangnam-gu | 2 |
| Izmir | 2 |
| La Garde | 2 |
| La Laguna | 2 |
| Totale | 597 |
| Nome | # |
|---|---|
| NEW NON-COVALENT INHIBITORS OF NLRP3 INFLAMMASOME ATPASE ACTIVITY, file e27ce42f-32eb-2581-e053-d805fe0acbaa | 551 |
| Covalent NLRP3 inhibitors: design strategies, synthesis and pharmacological characterization, file e27ce42f-1c0a-2581-e053-d805fe0acbaa | 355 |
| Design and synthesis of encorafenib-based BRAF-V600E degraders, file d8e03593-a5c7-4f96-9d2b-d9bc3af47ed2 | 238 |
| Targeting NLRP3 inflammasome: development of new covalent and non-covalent inhibitors of ATPase activity, file e27ce42e-c9c8-2581-e053-d805fe0acbaa | 34 |
| Pharmacological characterization of new NLRP3 inflammasome inhibitors., file e27ce430-5aa6-2581-e053-d805fe0acbaa | 17 |
| Investigation into the Use of Encorafenib to Develop Potential PROTACs Directed against BRAFV600E Protein, file d8cded6f-e57e-4e8c-87da-877e19c5510e | 11 |
| Totale | 1.206 |
| Categoria | # |
|---|---|
| all - tutte | 2.093 |
| article - articoli | 0 |
| book - libri | 0 |
| conference - conferenze | 2.019 |
| curatela - curatele | 0 |
| other - altro | 0 |
| patent - brevetti | 0 |
| selected - selezionate | 0 |
| volume - volumi | 0 |
| Totale | 4.112 |
| Totale | Lug | Ago | Sett | Ott | Nov | Dic | Gen | Feb | Mar | Apr | Mag | Giu | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2019/2020 | 333 | 0 | 0 | 0 | 0 | 0 | 31 | 64 | 34 | 45 | 56 | 71 | 32 |
| 2020/2021 | 141 | 29 | 21 | 22 | 11 | 4 | 3 | 15 | 7 | 8 | 7 | 1 | 13 |
| 2021/2022 | 223 | 12 | 13 | 123 | 10 | 2 | 6 | 5 | 12 | 13 | 8 | 8 | 11 |
| 2022/2023 | 216 | 17 | 18 | 5 | 19 | 10 | 46 | 31 | 15 | 17 | 10 | 22 | 6 |
| 2023/2024 | 293 | 23 | 15 | 23 | 36 | 26 | 27 | 54 | 52 | 5 | 29 | 3 | 0 |
| Totale | 1.206 | ||||||||||||